Literature DB >> 11594552

A critical birth weight and other determinants of survival for infants with severe intrauterine growth restriction.

M J Lee1, E L Conner, L Charafeddine, J R Woods, G Del Priore.   

Abstract

Our objective was to assess the perinatal management and neonatal outcomes of premature, severely intrauterine growth-restricted (IUGR) neonates. A cohort of neonates <1000 grams, < or = first percentile for weight, and <37 weeks' gestation was identified and matched 2:1 to two control sets of premature, appropriate-for-gestational age (AGA) infants-one with similar gestational age (AGA-GA group) and the other with similar birth weight (AGA-BW group) to determine the effect of IUGR on the outcome of the premature infant. The IUGR group was then examined in detail for descriptive statistics. Data were analyzed by t-tests and Chi-square analyses where appropriate. The IUGR infants had worse outcomes than AGA-GA controls but had somewhat better results than the AGA-BW controls. In the IUGR group, a birth weight less than 550 grams was significantly associated with neonatal death (p < 0.001). However, increasing gestational age was not associated with neonatal survival (p = 0.661) if birthweight remained below 550 grams. Classical cesarean delivery was associated with neonatal death (p = 0.003). Neonatal variables associated with poor outcome included patent ductus arteriosus (p = 0.034), feeding intolerance (p = 0.046), and failure to thrive (p = 0.05). Overall, neonatal survival was 73%. Of the surviving neonates, 69% had evidence of neurodevelopmental delay when tested at 6 and 12 months. Premature, growth-restricted neonates with birth weights of <550 grams versus those of >550 grams have dismal outcomes despite a gestational age that is compatible with survival.

Entities:  

Mesh:

Year:  2001        PMID: 11594552     DOI: 10.1111/j.1749-6632.2001.tb03813.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

1.  A sensitive functional assay reveals frequent loss of genomic imprinting in human placenta.

Authors:  Luca Lambertini; Andreas I Diplas; Men-Jean Lee; Rhoda Sperling; Jia Chen; James Wetmur
Journal:  Epigenetics       Date:  2008-09-07       Impact factor: 4.528

2.  STRIDER: Sildenafil Therapy In Dismal prognosis Early-onset intrauterine growth Restriction--a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis.

Authors:  Wessel Ganzevoort; Zarko Alfirevic; Peter von Dadelszen; Louise Kenny; Aris Papageorghiou; Aleid van Wassenaer-Leemhuis; Christian Gluud; Ben Willem Mol; Philip N Baker
Journal:  Syst Rev       Date:  2014-03-11

3.  STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials.

Authors:  A Pels; L C Kenny; Z Alfirevic; P N Baker; Peter von Dadelszen; C Gluud; C T Kariya; B W Mol; A T Papageorghiou; A G van Wassenaer-Leemhuis; W Ganzevoort; K M Groom
Journal:  BMC Pregnancy Childbirth       Date:  2017-12-28       Impact factor: 3.007

4.  Influence of Gestational Age at Initiation of Antihypertensive Therapy: Secondary Analysis of CHIPS Trial Data (Control of Hypertension in Pregnancy Study).

Authors:  Anouk Pels; Ben Willem J Mol; Joel Singer; Terry Lee; Peter von Dadelszen; Wessel Ganzevoort; Elizabeth Asztalos; Laura A Magee
Journal:  Hypertension       Date:  2018-04-23       Impact factor: 10.190

5.  Restored intestinal integrity, nutrients transporters, energy metabolism, antioxidative capacity and decreased harmful microbiota were associated with IUGR piglet's catch-up growth before weanling.

Authors:  Chang Cui; Caichi Wu; Jun Wang; Ziwei Ma; Xiaoyu Zheng; Pengwei Zhu; Nuan Wang; Yuhua Zhu; Wutai Guan; Fang Chen
Journal:  J Anim Sci Biotechnol       Date:  2022-10-14

Review 6.  Sildenafil during the 2nd and 3rd Trimester of Pregnancy: Trials and Tribulations.

Authors:  Felix Rafael De Bie; David Basurto; Sailesh Kumar; Jan Deprest; Francesca Maria Russo
Journal:  Int J Environ Res Public Health       Date:  2022-09-06       Impact factor: 4.614

7.  Sildenafil citrate for the management of fetal growth restriction and oligohydramnios.

Authors:  Rana Choudhary; Kavita Desai; Hetal Parekh; Kedar Ganla
Journal:  Int J Womens Health       Date:  2016-08-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.